Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Shares Outstanding (2020 - 2022)

Historic Shares Outstanding for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $83.3 million.

  • Atea Pharmaceuticals' Shares Outstanding rose 28.97% to $83.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was $83.3 million, marking a year-over-year increase of 28.97%. This contributed to the annual value of $83.1 million for FY2021, which is 80.76% up from last year.
  • Atea Pharmaceuticals' Shares Outstanding amounted to $83.3 million in Q3 2022, which was up 28.97% from $83.3 million recorded in Q2 2022.
  • Atea Pharmaceuticals' 5-year Shares Outstanding high stood at $83.3 million for Q3 2022, and its period low was $10.1 million during Q1 2020.
  • In the last 3 years, Atea Pharmaceuticals' Shares Outstanding had a median value of $82.8 million in 2021 and averaged $63.1 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first surged by 72144.74% in 2021, then increased by 28.97% in 2022.
  • Quarter analysis of 3 years shows Atea Pharmaceuticals' Shares Outstanding stood at $82.4 million in 2020, then increased by 0.81% to $83.1 million in 2021, then increased by 0.22% to $83.3 million in 2022.
  • Its Shares Outstanding stands at $83.3 million for Q3 2022, versus $83.3 million for Q2 2022 and $83.3 million for Q1 2022.